Skip to main content

Posts Tagged ‘pharmaceuticals’

Blog Image.forrester Q1 02

Perficient Recognized in Forrester’s AI Services Landscape

As we step into 2024, the transformative impact of Artificial Intelligence (AI) and generative AI on enterprise-level organizations has reshaped the business landscape in profound ways. The continual evolution of these technologies has empowered businesses to leverage advanced algorithms, predictive modeling, and generative capabilities, driving unprecedented innovation and efficiency. From enhancing decision-making processes to revolutionizing […]

FDA Director: We’re Watching How You Manage Product Complaints

We frequently blog about FDA Warning Letters and other regulatory and compliance issues that revolve around traditional pharmaceuticals and medical devices. However, one product segment that we haven’t yet discussed is digital health. This is because digital health products are fairly new to the market and most are still trying to figure out how FDA […]

Improving Clinical Operations with Enterprise Mobility

Last month, I read an article on the announcement from Apple’s CEO Tim Cook that stated Eli Lilly bought 15,000 iPads. The article, focusing on Apple’s mobility partner program, framed this as big news about Apple. I assume this will also significantly contribute to the Apple and IBM partnership as they build big data and analytics enterprise […]

New Technologies Will Improve Medication Adherence

Medication non-adherence continues to be a big issue in the pharma industry, affecting clinical outcomes for both approved and investigational drugs. Sponsors, research organizations, and payers are looking to verify that what they’re studying or paying for is actually being used as directed. Various technologies, such as Proteus and AiCure, are being examined for these […]